http://www.unboundmedicine.com/medline/ebm/research/disopyramideUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19915794/full_citation/Torsades_de_Pointes_induced_by_a_combination_of_garenoxacin_and_disopyramide_and_other_cytochrome_P450_family_3_subfamily_A_polypeptide_4_influencing_drugs_during_hypokalemia_due_to_licorice_Miyamoto K, Kawai H, Aoyama R, et al. 
Torsades de Pointes induced by a combination of garenoxacin and disopyramide and other cytochrome P450, family 3, subfamily A polypeptide-4-influencing drugs during hypokalemia due to licorice. [JOURNAL ARTICLE]
Clin Exp Nephrol 2009 Nov 14.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19829181/full_citation/Short_QT_Syndrome:_A_Review_Patel U, Pavri BB 
Short QT Syndrome: A Review. [Journal Article]
Cardiol Rev 2009 Nov-Dec; 17(6):300-3.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19786086/full_citation/Prediction_of_phospholipidosis_inducing_potential_of_drugs_by_in_vitro_biochemical_and_physicochemical_assays_followed_by_multivariate_analysis_Kuroda Y, Saito M 
Prediction of phospholipidosis-inducing potential of drugs by in vitro biochemical and physicochemical assays followed by multivariate analysis. [JOURNAL ARTICLE]
Toxicol In Vitro 2009 Sep 25.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19632526/full_citation/Quantitative_assessment_of_cibenzoline_administration_for_vagally_mediated_paroxysmal_atrial_fibrillation_using_frequency_domain_heart_rate_variability_analysis_Miyakoshi M, Ikeda T, Miwa Y, et al. 
Quantitative assessment of cibenzoline administration for vagally mediated paroxysmal atrial fibrillation using frequency-domain heart rate variability analysis. [Journal Article]
J Cardiol 2009 Aug; 54(1):86-92.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19624648/full_citation/Cardiopulmonary_exercise_testing_diagnosis_of_myocardial_suppression_Sinclair RC, Danjoux GR 
Cardiopulmonary exercise testing diagnosis of myocardial suppression. [Case Reports, Letter]
Anaesthesia 2009 Jul; 64(7):788-9.
Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19585724/full_citation/Drug_induced_hypoglycaemia_Drug-induced hypoglycaemia. [Journal Article]
Prescrire Int 2009 Apr; 18(100):67.
Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19520330/full_citation/New_trends_in_treatment_of_hypertrophic_cardiomyopathy_Hagège AA, Desnos M 
New trends in treatment of hypertrophic cardiomyopathy. [Journal Article]
Arch Cardiovasc Dis 2009 May; 102(5):441-7.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19498275/full_citation/Effects_of_Antiarrhythmic_Drugs_on_the_Hyperpolarization_Activated_Cyclic_Nucleotide_Gated_Channel_Current_Tamura A, Ogura T, Uemura H, et al. 
Effects of Antiarrhythmic Drugs on the Hyperpolarization-Activated Cyclic Nucleotide-Gated Channel Current. [JOURNAL ARTICLE]
J Pharmacol Sci 2009 Jun 5.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19446431/full_citation/[Drug_treatment_for_hypertrophic_cardiomyopathy]Gibelin P 
[Drug treatment for hypertrophic cardiomyopathy] [English Abstract, Journal Article]
Presse Med 2009 Jun; 38(6):1001-4.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19352335/full_citation/Provokable_left_ventricular_outflow_tract_obstruction_in_a_patient_without_hypertrophy_Pasquale F, Tomé-Esteban MT, Morgagni R, et al. 
Provokable left ventricular outflow tract obstruction in a patient without hypertrophy. [Journal Article]
Nat Rev Cardiol 2009 Apr; 6(4):313-6.
Abstract | Full Citation